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Abstract
Objective. To describe the different surgical techniques for
nasopharyngeal endoscopic resection (NER) and to support
the efficacy of the endoscopic endonasal approach in the
management of selected primary and locally recurrent naso-
pharyngeal tumors (NPTs).
Study Design. Case series with chart review.
Setting. Patients affected by NPTs who underwent NER
from 1997 to 2011 at two Italian referral centers.
Subjects and Methods. NER was tailored to the NPT exten-
sion and classified as follows: type 1 NER, resection of the
posterior nasopharyngeal wall; type 2 NER, resection super-
iorly extended to the sphenoid; type 3 NER, trans-pterygoid
approach to the postero-lateral nasopharynx with removal
of pterygoid plates and Eustachian tube, under control of
parapharyngeal-petrous-cavernous segments of the internal
carotid artery.
Results. Thirty-six consecutive patients with primary (9
cases) or locally recurrent (27 cases) NPTs were enrolled.
The lesions were staged as follows: stage I, 16 (44.4%); stage
II, 3 (8.4%); stage III, 15 (41.6%); and stage IVA, 2 (5.6%).
Type 1 NER was performed in 6 cases, type 2 NER in 12,
type 3 NER in 16, and bilateral-extended type 3 NER in 2.
No perioperative mortality or major complications were
observed. Postoperatively, 11 patients received intensity-
modulated radiotherapy, with or without chemotherapy.
Follow-up ranged from 2 to 173 months (mean: 38 months).
Five years overall, disease-specific, and disease-free survivals
were 75.1% 6 9.13%, 80.9% 6 7.79%, and 58.1% 6 14.8%,
respectively.
Conclusion. NER is a feasible and minimally invasive surgical
approach for the management of selected primary and
locally recurrent NPTs. Our preliminary outcomes are pro-
mising, with local control rates comparable to those of con-
ventional procedures. Larger case series and longer follow-
up are needed to validate the reproducibility and efficacy of
the technique.
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Introduction
Radiotherapy (RT) associated or not with chemotherapy
(CHT) is the gold standard of treatment for nasopharyngeal
carcinoma (NPC).1 Except for selected histotypes, surgery is
mostly limited to tissue sampling or to salvaging selected
patients with residual or persistent local or recurrent regional
tumor. External approaches have been extensively described,2,3
while only a few studies concerning endoscopic endonasal
techniques have been reported.4,5 The first experiences dealing
with the endoscopic endonasal approaches were encouraging,
showing adequate visualization of tumor margins with com-
plete oncologic resection, thus avoiding facial scarring or
deformity and preserving the neurologic and masticatory func-
tion.6,7 At the present time, the major technical challenge
encountered when accessing this area through the endonasal
corridor still remains the restricted working space in proximity
of critical neurovascular structures. Greater anatomical knowl-
edge, refinement of imaging techniques, and the evolution of
surgical expertise in endoscopic endonasal approaches have all
contributed in the effort devoted to overshooting the present-
day surgical limits.8 In this study, we describe different surgi-
cal endoscopic endonasal approaches to the nasopharynx,
depending on the local extension of the disease. Moreover, we
evaluate the reproducibility, complications, and outcomes of
endoscopic endonasal surgery in the management of
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selected primary and locally recurrent nasopharyngeal
tumours (NPTs).
Methods
We performed a retrospective analysis of patients affected by
primary and locally recurrent NPTs, treated with curative
intent through an endoscopic endonasal approach at 2 Italian
tertiary care centers, from January 1997 to December 2011.
Approval was obtained from the Varese and Brescia
Institutional Review Boards. All the patients gave their
informed consent to participate in this survey. All the NPTs
were staged according to the American Joint Committee on
Cancer (AJCC) staging system, 7th edition.
Endoscopic examination and imaging studies such as
computed tomography (CT) and magnetic resonance (MR)
were used to evaluate the local extension of the tumor.
Regional or distant dissemination of disease was preopera-
tively excluded by performing neck ultrasound and total
body PET-CT scan. Moreover, an angio-CT scan (and/or
intracranial angiography) was always obtained in order to
clearly define anatomic variations of the parapharyngeal and
paraclival course of the internal carotid artery (ICA). When
the NPT was in relation with the parapharyngeal, petrous,
or cavernous segment of the ICA, without encasement of
the vessel but requiring an expanded endonasal resection,
the possibility of intravascular stent placement was consid-
ered. The ICA stenting was helpful for improving the surgi-
cal management of the vessel, protecting it from iatrogenic
injuries, and reducing postoperative risk of complication,
especially regards the parapharyngeal segment of the ICA
that requires consistency and stability among the muscular
planes to be managed safely. The carotid stenting was per-
formed under general anesthesia as a separate procedure,
sometimes during diagnostic angiography. The Solitaire AB
Neurovascular Remodelling Device (ev3 Inc, Plymouth,
Minnesota) was the self-expanding stent employed. To
reduce the risk of thromboembolic complications, a dual
antiplatelet therapy was administrated for 30 days after
stenting and then reduced to single-drug treatment.
Contraindications
Patients were considered unsuitable for nasopharyngeal
endoscopic resection (NER) in the case of massive intracra-
nial intradural involvement, orbital content invasion, and
encasement of the ICA by the tumor.
Surgical Technique
Hypotensive general anesthesia was performed in all cases.
A perioperative prophylactic antibiotic regimen included
third-generation cephalosporin with cerebral spinal fluid
penetration. The nasal cavities were packed prior to surgery
with cottonoids soaked in 2% oxymetazoline, 1% oxybupro-
caine and adrenaline (1/100.000) solution for 10 minutes, to
reduce bleeding and improve transnasal access in terms of
operative space. The extent of surgical resection was classi-
fied into 3 subtypes according to the extension of disease.7
Type 1 NER started with the removal of the posterior
portion of the nasal septum. The resection was limited to
the postero-superior nasopharyngeal wall, reaching the bony
floor of the sphenoid sinus superiorly and the pharyngo-
basilar/prevertebral fascia posteriorly. Type 2 NER was
superiorly extended to include also the anterior wall and the
floor of the sphenoid sinus. In this case, the sphenoid ros-
trum and the intersphenoidal septum were removed. Type 3
NER was extended laterally to include the lateral nasophar-
yngeal wall and the cartilaginous portion of the Eustachian
tube. An ipsilateral endoscopic medial maxillectomy with
the removal of the inferior turbinate, medial maxillary wall,
and naso-lacrimal duct was extended as far as the pyriform
aperture. In selected cases, a modified Denker approach was
performed to enlarge the surgical corridor. The posterior
wall of the antrum was drilled out to provide good exposure
of the tumor. The sphenopalatine artery (SPA), the greater
palatine artery, the vidian bundle, and the palato-vaginal
artery were exposed, cauterized, and cut in order to mobilize
laterally the soft tissues within the pterygo-palatine fossa.
Only the septal branches of the SPA are spared when a
naso-septal flap is needed for reconstruction; nevertheless,
the other branches are resected for improving the storage
of the flap in the antrum. Taking advantage of the trans-
ethmoid-pterygoid approach with the drilling out of the
medial and lateral pterygoid plates, the postero-lateral
nasopharynx was removed together with the cartilaginous
tube, the peritubaric muscles (levator and tensor veli pala-
tine), and the upper portion of the pterygoid muscles. To
perform these steps safely, it was mandatory to identify
and have control of the parapharyngeal, petrous, and caver-
nous segments of the ICA. Medially, the vidian canal was
a useful landmark for recognizing the junction between the
intrapetrous and paraclival segments of the ICA. Once the
lacerum segment of the ICA was identified, the bone of its
horizontal petrous segment was carefully removed.
Laterally, the cartilaginous portion of the Eustachian tube
was resected as far as the bony tube, which was a critical
landmark for recognizing the junction between the intrape-
trous and parapharyngeal segments of the ICA (Figure 1).
The musculo-tubal canal, the spine of the sphenoid bone with
the sphenomandibular ligament, and the foramen spinosum
(with the middle meningeal artery) were critical landmarks
that were very useful to the surgeon as guides for identifying
the carotid canal. From an anterior to posterior viewpoint, an
anatomical sequence could be used to localize the carotid
canal: foramen ovale, foramen spinosum, spine of the sphe-
noid bone, musculo-tubal canal, and carotid canal (Figure
2). In all the cases, the surgical margins were carefully exam-
ined with frozen section and the surgical procedure was con-
tinued until the tissue margins were clear of tumor or until
further resection was impossible due to invasion of critical
structures. A magnetic navigation image guidance system
(Medtronic Navigation, Inc, Louisville, Colorado) was used
intraoperatively for laterally extended tumors to recognize
specific anatomical landmarks orienting the surgeon during
the procedure. The angio-CT and MR images were processed
with the fusion software of the navigation system to increase
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the safety of the surgery. An acoustic Doppler ultrasound
probe was also employed for the identification of critical ves-
sels. The surgical wound was left free to heal by secondary
intention in cases of types 1 and 2 NER; when an expanded
resection with exposure of the ICA and/or skull base was per-
formed (selected cases of type 3 NER), the surgical field was
resurfaced using a pedicled flap (Hadad-Bassagaisteguy flap in
most of the cases) harvested at the beginning of surgery and
temporarily stored in the antrum during the demolition phase.
When the tumor was bilaterally extended involving the nasal
septum, for defects too large to be covered, or in the case of
radiation-induced degeneration of the nasal mucosa, a
temporo-parietal fascia flap (TPFF) was harvested and inserted
into the nose through a trans-pterygoid tunnel.9,10 Otherwise,
the field was covered by fascial grafts. Nasal packing was
removed 24 to 48 hours after the surgical procedure.
Statistical Analysis
All data were collected and processed with a commercially
available computer software package (SPSS for Windows,
Version 19, 2010, SPSS, Inc, Chicago, Illinois). The esti-
mated distribution of the overall survival (OS), disease-
specific survival (DSS), and disease-free survival (DFS) was
calculated using the Kaplan–Meier method and the log-rank
test. Univariate and multivariate analyses of survival were
carried out using an explorative Cox-proportional hazards
model, considering P-values below .05 as significant.
Results
According to the selection criteria adopted, 36 consecutive
patients with primary (9 cases) or locally recurrent (27
cases) NPTs were enrolled in this survey. Among the group
Figure 1. Step-by-step endoscopic transnasal nasopharyngectomy. (A) Type 1 NER; (B) type 2 NER; (C) endoscopic medial maxillectomy;
(D) surgical field after removal of pterygoid plates; (E) relationship between cartilaginous Eustachian tube, vidian nerve, and ICA; (F) rela-
tionship between bony Eustachian tube and ICA. Abbreviations: A, atlas; bET, bony Eustachian tube; C, clivus; cICA, cavernous ICA; ET,
Eustachian tube; GPA, greater palatine artery; ICA, internal carotid artery; IMA, internal maxillary artery; LPM, lateral pterygoid muscle;
LVPM, levator veli palatine muscle; MS, maxillary sinus; NER, nasopharyngeal endoscopic resection; PCA, paraclival carotid artery; ppICA,
parapharyngeal ICA; S, septum; SS sphenoidal sinus; SSF, sphenoidal sinus floor; T, torus tubaricus; V2, second branch of the trigeminal
nerve; V3, third branch of the trigeminal nerve; VN, vidian nerve.
Figure 2. Osteologic representation of the sequence of anatomi-
cal structures useful for safely localizing the carotid canal intrao-
peratively: foramen ovale (FO), foramen spinosum (FS), spine of
the sphenoid bone (spS), musculo-tubal canal (red arrow), and
finally, the carotid canal (CC). Abbreviations: FL, foramen lacerum;
JF, jugular foramen; M, mastoid process; OC, occipital condyle; SP,
styloid process.
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with recurrent disease, 20 patients had been treated previ-
ously with chemoradiation therapy, associated with radical
neck dissection in 4 cases; 6 patients received radiotherapy
alone; and 1 patient chemotherapy alone. The lesions were
staged as follows: stage I, 16 (44.4%) patients; stage II, 3
(8.4%) patients; stage III, 15 (41.6%) patients; and stage
IVA, 2 (5.6%) patients. The histotypes encountered were
the recurrence of undifferentiated carcinoma of nasopharyn-
geal type (UCNT) (WHO type III) (19/36, 53%), squamous
cell carcinoma (WHO, type I-II) (4/36, 11%), adenoid
cystic carcinoma (4/36, 11%), adenocarcinoma (4/36, 11%),
plasmocytoma (2/36, 5.5%), sarcoma (2/36, 5.5%), and mel-
anoma (1/36, 3%). All surgeries were performed through an
endoscopic endonasal approach with curative intent. Only 1
patient with recurrent UCNT presented with cervical metas-
tases (staged rT1N1M0), thus requiring a neck dissection as
part of the surgical treatment. Type 1 NER was performed
in 6 cases, type 2 NER in 12 cases, type 3 NER in 18 cases
(monolateral in 16 cases and bilateral-extended in 2 cases).
Preoperative ICA stenting was performed in 2 cases of type
3 NER because of the close relationship between the tumor
and the vessel (lacerum segment in one case, parapharyn-
geal portion in the other one). In our limited experience,
this procedure obtained good results in terms of ICA preser-
vation and surgical ability to maneuver instruments and to
dissect. Moreover, 16 of the 18 extended nasopharyngec-
tomies (type 3 NER) had been performed in recent years
(after 2006), and the surgical wound was covered with
either a pedicled nasoseptal flap or a TPFF, tailored to the
extension of the tumor and the resulting defect, to speed the
healing process and to decrease the risk of complications. In
our series, we did not have to convert the endoscopic
approach to a traditional open procedure in any of the
patients. The margin status, assessed with intraoperative
frozen section and confirmed with the definitive histopatho-
logical results, was negative in 92% (33/36) of the cases. In 3
patients with recurrence of UCNT, the radiation-induced scars
and necrosis of the tissues had made the tumor incompatible
with safe radical surgical clearance, whether endoscopic or
open, unless at the cost of sacrificing the ICA. No
perioperative mortality or major complications were observed
in our series. Minor complications, alone or combined,
occurred in 9 of 36 patients: occipital headache (2 cases of
type 1 NER, 1 case of type 2 NER, and 5 cases of type 3
NER), numbness of the hard palate ipsilateral to the surgical
resection (2 cases of type 3 NER), persistent glue ear with dis-
abling conductive hearing loss (4 cases of type 3 NER), and
temporary postoperative masticatory impairment (3 cases of
type 3 NER). However, no patients reported either masticatory
deficits or impaired swallowing in a long-term follow-up.
Mean hospitalization stay was 7.2 days (range, 2-14) and all
patients were discharged with nasal irrigation with saline solu-
tion and systemic antibiotic therapy. Postoperative adjuvant
treatments were administered to 11 of 36 (30.5%) patients,
including 7 of 9 primary NPTs who received intensity-
modulated radiation therapy and 4 of 27 recurrent NPTs (who
received chemotherapy alone in 2 cases and chemoradiation
therapy in 2 cases). Follow-up ranged from 2 to 173 months
(mean: 38 months; median: 32.5 months). At the time of the
last follow-up, 24 (67%) patients were free of disease (but
only 5 of them had actually reached the minimum 5 years of
follow-up), 5 (13.7%) were alive with disease, 1 (2.7%) had
died of other causes (acute respiratory failure), and 6 (16.6%)
had died of the disease (Table 1). Considering the entire study
population, the 5 years overall, disease-specific, and disease-
free survivals were 75.1% 6 9.13%, 80.9% 6 7.79%, and
58.1% 6 14.8%, respectively (Figure 3). Remarkably, the
survival rates analyzed in the group of recurrent NPTs were
poorer, with the 5 years overall, disease-specific, and disease-
free survivals of 72.5% 6 10.8%, 79.8% 6 9.1%, and 55.6%
6 17.8%, respectively.
Discussion
The management of patients with recurrent nasopharyngeal
cancers is a difficult undertaking with poor prognosis and
recurrence rates ranging from 19% to 56%, depending on
the initial stages of disease.11,12 Surgery could be one
option of treatment for this subset of patients, among a vari-
ety of modern re-irradiation protocols including stereotactic,
brachytherapy, proton, or intensity modulated therapy.13,14
Table 1. Outcomes and follow-up status of primary and locally recurrent nasopharyngeal tumors included in this case series, according to
the T classification at presentation.
Follow-Up
Presentation T Classification Status Months
Primary 5, T1 4 NED, 1DOD 12-53 (mean, 31)
1, T2a 1 DOD 173
2, T3 1 NED, 1 AWD 32, 41
1, T4 1 AWD 119
Recurrent 12, rT1 10 NED, 1 DOD, 1 DOC 5-137 (mean, 37)
1, rT2a 1 NED 59
13, rT3 8 NED, 2 AWD, 3 DOD 2-85 (mean, 26)
1, rT4 1 AWD 3
Abbreviations: AWD, alive with disease; DOC, dead of other causes; DOD, dead of disease; NED, no evidence of disease.
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External surgical approaches have been described as a pos-
sible treatment in cases of recurrent NPTs, but entailing
non-negligible morbidity for the patient. In the past few
years, endoscopic endonasal procedures have been proposed
as an alternative to traditional external approaches, not only
for the management of recurrent nasopharyngeal carcinoma
but also as a method of primary treatment for selected can-
cers, with glandular or mesenchymal differentiation, which
are considered not suitable for RT and/or CHT. NER allows
reaching the nasopharynx where the cancer is located by
passing through the nasal fossae without the need for the
skin incisions and maxillary osteotomies that are frequently
associated with persistent or transitory complications such
as chronic dacryocystitis, cheek paraesthesia, and temporary
diplopia. Endoscopes also provide magnified images and the
possibility to explore around corners, thanks to their angled
view, so that the tumor margins can be well identified and
controlled. The anatomic limits for safe NER are the dura
of the posterior cranial fossa posteriorly and the ICA later-
ally, requiring a careful preoperative study of these struc-
tures to avoid major neurovascular complications.15 To
expose and preserve these critical structures intraopera-
tively, we perform a posterior septectomy associated with a
large medial maxillectomy (and/or modified Denker
approach) in order to remove the posterior wall of the
antrum, to mobilize the soft tissue of the pterygopalatine
fossa, and then to remove the pterygoid processes and carti-
laginous portion of the Eustachian tube.16 In this manner,
we obtain enough surgical space to perform a careful and
precise bimanual dissection according to the ‘‘two-nostrils
four-hands technique.’’17 In addition, this approach allows
control of the parapharyngeal, petrous, and cavernous seg-
ments of the ICA, which is a critical step for safely and
completely resecting laterally extended nasopharyngeal can-
cers.6 Anatomically speaking, we stress the importance of
working at the level of the skull base where there are sound
bony landmarks that can guide to the identification of the
upper parapharyngeal portion of the ICA. On the contrary,
no landmark can be considered safe within the parapharyn-
geal space because of the possibility of looping or kinking
of the vessel. In fact, also the styloid muscles, which cover the
major vessels (ICA and internal jugular vein) laterally at skull
base level and in the upper parapharyngeal space, more infer-
iorly can be overtaken anteriorly by the ICA, thus posing at
extreme risk an endoscopic endonasal surgery based on their
role.18 Once the carotid canal has been exposed, the artery is
identified and it can be followed under visual control
within the parapharyngeal space. Ultrasound tools should
be used in this kind of procedure to increase the ability to
localize the vessel. Furthermore, the ICA stenting is a pre-
operative procedure that must be discussed with selected
patients affected by laterally extended tumors; its aim is to
protect the vessel from iatrogenic injuries and help the sur-
geon in the identification and dissection of the lesion
intraoperatively. On the other hand, the patient should be
informed that this intravascular procedure requires long-
term antiplatelet therapy. However, previous experiences
with ICA stenting for different surgical approaches con-
firmed our impression that neither major complications nor
significant patient morbidity occur with this procedure.19-
21 When the ICA and posterior/middle skull base were dis-
sected and exposed, the surgical field was resurfaced using
a pedicled nasoseptal flap or TPFF to promote the healing
and to protect the neurovascular structures exposed, espe-
cially in the cases requiring adjuvant radiotherapy.
Our study was a preliminary evaluation of the results con-
cerning the endoscopic management of primitive or locally
recurrent nasopharyngeal tumours, focusing on surgical tech-
niques, perioperative complications, and local control of the
disease. The actuarial overall survival rate in our series was
75%, decreasing to 58% when considering the disease-free sur-
vival rate, with a mean follow-up of 38 months (median: 32.5
months). Unfortunately, a significant statistical evaluation is
not possible at the time of writing, on account of the small
size of the patient cohort, the heterogeneous group of histo-
types, and the limited follow-up. However, our survival rates
were similar to the results of the other endoscopic endonasal
experiences and they were comparable also with the outcomes
after conventional open surgery procedures, emphasizing the
aggressive biological behavior of malignant nasopharyngeal
tumours, regardless of the surgical approach. Nevertheless, our
data could support the feasibility and good tolerability of the
endoscopic endonasal approaches in selected nasopharyngeal
cancers. It is essential to remember that adequate patient
Figure 3. Kaplan–Meier survival rates of the population enrolled in the study. (A) 5 years overall survival of 75.1% 6 9.13%; (B) 5 years
disease-specific survival of 80.9% 6 7.79%; (C) 5 years disease-free survival of 58.1% 6 14.8%.
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selection for NER is the critical point for avoiding major
neurovascular complications, persistence of tumor, or
having to convert to an open approach. Encasement of
cavernous, petrous, or parapharyngeal segments of the ICA
and massive intracranial extension toward the middle or
posterior cranial fossa still remain absolute contraindica-
tions to an endoscopic endonasal resection with curative
intent. Moreover, we emphasize that its indications and use
are limited not only by the comorbidities of patient and the
extent of disease, but also by the skill of the surgeon and
by the availability of dedicated surgical instruments and
intraoperative devices.
In conclusion, endoscopic endonasal nasopharyngectomy
seems to be a feasible and minimally invasive surgical
approach for managing selected primary and locally recurrent
NPTs. Larger case series and longer follow-up are needed to
validate the reproducibility and the outcomes of this technique.
A future challenge regarding minimally invasive techniques
for accessing the nasopharynx could be the development of
robotic-assisted surgery, alone or combined with the transnasal
endoscopic approaches.22 The combined and blended solution,
pioneered by the Ohio group, could probably overcome the
limits of current technologies.23 Taking advantage of the trans-
oral corridor, the whole nasopharynx could be exposed with
complete visualization of the ICA and the Eustachian tube
bilaterally.24 However, the 3-dimensional perspective and the
considerable maneuverability of the surgical instruments have
to be balanced with the need for a palatal incision that still
remains the main disadvantage.25
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